Incannex Healthcare (IXHL) Enterprise Value (2020 - 2026)
Incannex Healthcare's (IXHL) quarterly Enterprise Value came in at -$74.5 million in Q1 2026, down 1010.12% year-on-year from $8.2 million in Q1 2025, and down 7.67% quarter-over-quarter from -$69.2 million in Q4 2025.
Incannex Healthcare (IXHL) Enterprise Value (2020 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Enterprise Value across 7 years of filings, most recently posting -$74.5 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$74.5 million, down 1010.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$74.5 million (down 1010.12% YoY), and the FY2025 annual result was -$15.0 million, down 154.9% from the prior year.
- Enterprise Value came in at -$74.5 million for Q1 2026 at Incannex Healthcare, down from -$69.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.1 million in Q4 2024 to a low of -$74.5 million in Q1 2026.
- The 5-year median for Enterprise Value is -$14.8 million (2023), against an average of -$27.8 million.
- Across the five-year window, Enterprise Value surged 85.58% in 2024 and tumbled 3198.05% in 2025, its largest moves.
- Incannex Healthcare's Enterprise Value stood at -$37.5 million in 2022, then soared by 61.19% to -$14.6 million in 2023, then soared by 85.58% to -$2.1 million in 2024, then sank by 3198.05% to -$69.2 million in 2025, then retreated by 7.67% to -$74.5 million in 2026.
- The last three Enterprise Value figures came in at -$74.5 million (Q1 2026), -$69.2 million (Q4 2025), and -$73.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -498.58 Mn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | -74.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.50 Mn |
| Dec 31, 2025 | -69.19 Mn |
| Sep 30, 2025 | -73.30 Mn |
| Jun 30, 2025 | -15.04 Mn |
| Mar 31, 2025 | -6.71 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -3.63 Mn |
| Jun 30, 2024 | -5.90 Mn |
| Mar 31, 2024 | -9.31 Mn |
| Dec 31, 2023 | -14.55 Mn |
| Jun 30, 2023 | -22.12 Mn |
| Jun 30, 2022 | -37.50 Mn |
| Jun 30, 2021 | -9.12 Mn |
| Jun 30, 2020 | -3.60 Mn |